Johnson & Johnson to Invest $2 Billion at State-Of-The-Art North Carolina Facility
On Aug. 21, 2025, Johnson & Johnson announced it will increase its presence in North Carolina with a…
Artificial Intelligence | Biotechnology | Diagnostics | Non-Profit Research | Oncology | Therapeutics
CPRIT Approves $27 Million In Grants for Cancer Research in Texas
On Aug. 20, 2025, The Cancer Prevention and Research Institute of Texas (CPRIT) announced the approval of 15…
Biggest shake-up in type 2 diabetes care in a decade announced
On Aug. 20, 2025, the National Institute for Health and Care Excellence (NICE) announced that millions of people…
In a Major Win for Vanda, a Federal Appeals Court Overturns FDA’s Order Denying Approval of Hetlioz for the Treatment of Jet Lag Disorder
On Aug. 18, 2025, Vanda Pharmaceuticals announced that it secured a landmark victory over the U.S. Food and…
Skyhawk Therapeutics Announces Strategic Collaboration with Merck to Discover Novel RNA-Targeting Small Molecules for Neurological Disorders
On Aug. 18, 2025, Skyhawk Therapeutics announces a strategic research collaboration with Merck KGaA, Darmstadt, Germany. The collaboration…
Biotechnology | Disease | FDA | Medicine | Therapeutics
Novo Nordisk lowers cost of Ozempic® to $499 per month for self-paying patients
On Aug. 18, 2025, Novo Nordisk announced the launch of a new offer that enables self-paying, eligible, type…
Biotechnology | Disease | FDA | Therapeutics
Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis
On Aug. 15, 2025, Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved a…
Precigen Announces FDA Approval of PAPZIMEOS, the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis
On Aug. 15, 2025, Precigen announced that the US Food and Drug Administration (FDA) has approved PAPZIMEOS™ (zopapogene imadenovec-drba)…
OHSU Knight Cancer Institute receives record $2 billion commitment from Phil and Penny Knight
On Aug. 14, 2025, Phil and Penny Knight announced a record-breaking $2 billion gift to the Oregon Health…
Using generative AI, researchers design compounds that can kill drug-resistant bacteria
On Aug. 14, 2025, with help from artificial intelligence, researchers from Massachusetts Institute of Technology (MIT) announced they…
Valley Fever Cases Continue to Rise in 2025 Following Record High in 2024
On Aug. 14, 2025, the California Department of Public Health (CDPH) is reminding California residents and visitors that…
Lilly signs $1.3 billion deal with Superluminal to discover obesity medicines using AI
On Aug. 14, 2025, Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines…
Researchers identify a potential biomarker for long COVID
On Aug. 11, 2025, Researchers from the Translational Genomics Research Institute (TGen), part of City of Hope, and…
Researchers test common Household disinfectants’ abilities to fight antibiotic resistance at the genetic level
On Aug. 11, 2025, University of Washington (UW) researchers announced the results of testing the efficacy of several…
Eliminating mosquitoes not enough to fight China’s chikungunya fever outbreak, experts say
On Aug. 8, 2025, experts in mosquito-borne infectious diseases are warning against excessive insect eradication campaigns as cities…
Novel immunologic surveillance study provides new insights into post-pandemic return of respiratory viruses
On Aug. 7, 2025, The first paper from a multi-year clinical research study has been published in The…
Scripps Scientists build an “evolution engine” to rapidly reprogram proteins
On Aug. 7, 2025, research scientists at Scripps Research announced a new platform that enables fast, scalable protein…
CareDx Announces Landmark KOAR Study Published in the American Journal of Transplantation
On Aug. 6, 2025, CareDx announced the publication of the Kidney Allograft Outcomes AlloSure Registry (KOAR) study in…
Jazz Pharmaceuticals Announces U.S. FDA Approval of Modeyso™ (dordaviprone) as the First and Only Treatment for Recurrent H3 K27M-mutant Diffuse Midline Glioma
On Aug. 6, 2025, Jazz Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Modeyso™ (dordaviprone)…
Washington Health Officials investigating possible locally acquired case of malaria
On Aug. 6, 2025, the Tacoma-Pierce County Health Department (TPCHD) reported an East Pierce County, Washington woman who…
Scientists Achieve Megabase-Scale Precision Genome Editing in Eukaryotic Cells
On Aug. 5, 2025, a team of Chinese researchers led by Prof. GAO Caixia from the Institute of…
Biotechnology | Diagnostics | Disease | Non-Profit Research | Therapeutics | Vaccine | Women's Health
Gates Foundation Announces Catalytic Funding to Spark New Era of Women-Centered Research and Innovation
On Aug. 4, 2025, The Gates Foundation announced a $2.5 billion commitment through 2030 to accelerate research and…
UK Biobank celebrates completion of world’s largest human imaging study with landmark events
On Aug. 4, 2025, UK Biobank announced it had reached a historic milestone – completing 100,000 whole-body imaging…
New York City Health Department Provides Update on Community Cluster of Legionnaires’ Disease in Central Harlem
On Aug. 4, 2025, the New York City Health Department provided an update on the investigation into a…
Mallinckrodt, Endo Complete Merger to Create Global, Scaled, Diversified Therapeutics Leader
Aug. 1, 2025, Mallinckrodt and Endo announced that they have completed their merger to create a global, scaled,…
MIT spinout Tissium secured FDA marketing authorization of biopolymer platform for nerve repair
On Aug. 1, 2025, Tissium announced it has begun offering surgeons a new solution based on a biopolymer…
Biotechnology | Disease | FDA | Therapeutics
FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B
On Jul. 31, 2025, Novo Nordisk announced that the US Food and Drug Administration (FDA) approved Alhemo® (concizumab-mtci)…
Biology | Diagnostics | Disease | Medicine | Therapeutics
Most U.S. adults have hearts older than their actual age
On Jul. 30, 2025, a study led by Northwestern Medicine shows that most U.S. adults have a “heart…
Researchers create ‘virtual scientists’ to solve complex biological problems
On Jul. 29, 2025, Stanford Medicine researchers announced the creation a team of virtual scientists backed by artificial…
Nature-Inspired Virtual Reality Boosts Emotional Well-Being In Older Adults Living With Dementia
On Jul. 29, 2025, Texas A&M study finds immersive VR nature experiences improve mood and quality of life….